Skip to main content
. 2021 Apr 27;21:214. doi: 10.1186/s12872-021-02032-3

Table 2.

Intraprocedural ACTs and the percentage of measurements at the target ACT

ACT (s) WG NG110 p WG NG120 p WG NG130 p
Baseline ACT 137 ± 44 128 ± 46 0.450 137 ± 44 127 ± 45 0.352 137 ± 44 129 ± 34 0.432
15 min-ACT 324 ± 65 289 ± 51 0.015 324 ± 65 285 ± 49 0.006 324 ± 65 306 ± 51 0.182
30 min-ACT 320 ± 61 279 ± 41 0.001 320 ± 61 286 ± 26 0.003 320 ± 61 306 ± 44 0.227
45 min-ACT 302 ± 58 270 ± 39 0.010 302 ± 58 277 ± 32 0.037 302 ± 58 292 ± 37 0.389
60 min-ACT 305 ± 72 282 ± 32 0.112 305 ± 72 280 ± 28 0.089 305 ± 72 296 ± 31 0.526
75 min-ACT 299 ± 55 279 ± 47 0.179 299 ± 55 278 ± 29 0.094 299 ± 55 292 ± 26 0.555
Percentage of measurements at the target ACT (%) 63.4 ± 36.2 73.4 ± 32.6 0.179 63.4 ± 36.2 82.2 ± 23.6 0.007 63.4 ± 36.2 84.8 ± 23.7 0.003

ACT activated clotting time